Natalizumab-induced thrombocytopenia: A case report

Authors

  • Amirreza Azimi Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Zohreh Abna Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Fereshteh Ghadiri Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Farzad Mehrabi Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.18502/cjn.v21i1.9363

Keywords:

Drug; Natalizumab; Immune Thrombocytopenia; Multiple Sclerosis; Therapeutics

Abstract

The article's abstract is not available.

Downloads

Published

2022-05-01

Issue

Volume (21) issue (1)

Section

Articles